Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 105351-105400 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT04041583
Clinical and Radiological Outcomes of Posterior Cervical Fusion Supplemented With Interfacet Spacers
N/ARecruiting
45 participants
Started: Sep 1, 2019 · Completed: Aug 31, 2025
1 condition2 sponsors1 location
NCT03787966
Attenuating Cancer Treatment-related Toxicity in Oncology Patients With a Tailored Physical Exercise Program
NARecruiting
110 participants
Started: Sep 1, 2019 · Completed: Jan 31, 2025
1 condition1 sponsor1 location
NCT04217408
Deep Brain Stimulation (DBS) for the Treatment of Refractory Obsessive-compulsive Disorder (OCD)
NAActive, not recruiting
10 participants
Started: Sep 1, 2019 · Completed: Dec 19, 2024
1 condition1 sponsor1 location
NCT05720572
Antazoline in Comparison to Propafenone in Pharmacological Cardioversion of Atrial Fibrillation.
PHASE4Recruiting
105 participants
Started: Sep 1, 2019 · Completed: Jan 1, 2026
1 condition1 sponsor1 location
NCT04371042
PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies
N/ARecruiting
5,000 participants
Started: Sep 1, 2019 · Completed: Dec 31, 2035
9 conditions1 sponsor1 location
NCT04513587
The Effect and Applicability of CBT-Based Weight Loss Treatment Model in Obese Patients With Comorbid Depression in Health Care
NARecruiting
80 participants
Started: Sep 1, 2019 · Completed: Dec 31, 2024
4 conditions5 sponsors1 location
NCT04334707
Kidney Precision Medicine Project
N/ARecruiting
1,000 participants
Started: Sep 1, 2019 · Completed: Jun 30, 2027
14 conditions23 sponsors8 locations
NCT04526743
Eating Behavior and Weight Trajectory After Bariatric Surgery
N/ARecruiting
500 participants
Started: Sep 1, 2019 · Completed: Sep 1, 2026
2 conditions1 sponsor1 location
NCT04024761
A Phase 1 Trial of CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation
PHASE1Active, not recruiting
50 participants
Started: Aug 31, 2019 · Completed: Dec 1, 2025
4 conditions2 sponsors2 locations
NCT03975049
Triplet Combination or Doublet Regimen Versus Chemoradiation as Neoadjuvant Therapy for Locally Advanced Rectal Cancer
PHASE3Not yet recruiting
933 participants
Started: Aug 31, 2019 · Completed: Jul 31, 2029
2 conditions1 sponsor0 locations
NCT04046523
Non-Invasive and Non-Contact Intracranial Pressure Waveform Recording Using Dynamic Video Ophthalmoscopy
NARecruiting
90 participants
Started: Aug 31, 2019 · Completed: Jul 31, 2030
1 condition3 sponsors1 location
NCT03911492
Canadian-American Spinal Cord Perfusion Pressure and Biomarker Study
NARecruiting
100 participants
Started: Aug 31, 2019 · Completed: Dec 31, 2025
4 conditions2 sponsors8 locations
NCT04054609
FAZA PET/MRI in CLI Patients Pre and Post Revascularization
NARecruiting
40 participants
Started: Aug 31, 2019 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03897543
ABX196 in Combination With Nivolumab in Patients With Hepatocellular Carcinoma
PHASE1/PHASE2Recruiting
48 participants
Started: Aug 30, 2019 · Completed: Jun 30, 2023
1 condition2 sponsors2 locations
NCT04091516
Feasibility & Implementation of a Plant-Based Weight-Loss Program in an Office-Based Setting
NAActive, not recruiting
75 participants
Started: Aug 30, 2019 · Completed: Dec 31, 2025
5 conditions1 sponsor1 location
NCT03945162
"Intravesical Photodynamic Therapy (PDT) in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer (NMIBC) Patients"
PHASE2Recruiting
125 participants
Started: Aug 30, 2019 · Completed: Dec 31, 2026
1 condition1 sponsor12 locations
NCT04084730
Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer
PHASE2Recruiting
280 participants
Started: Aug 30, 2019 · Completed: Aug 30, 2026
6 conditions1 sponsor9 locations
NCT03642028
Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic Stress
PHASE4Recruiting
190 participants
Started: Aug 30, 2019 · Completed: Dec 31, 2025
2 conditions1 sponsor4 locations
NCT03876951
Evaluation of the Accuracy of Percutaneous Biopsy by Vacuum-assisted Biopsy (VAB) to Assess Pathological Complete Response in Patients With Clinical and Radiological Complete Response After Neoadjuvant Chemotherapy (NeoVAB)
NAActive, not recruiting
67 participants
Started: Aug 30, 2019 · Completed: Apr 8, 2025
1 condition1 sponsor1 location
NCT05189314
RFA of Benign Thyroid Nodules: Clinical Outcomes and Quality of Life Study
N/ARecruiting
100 participants
Started: Aug 30, 2019 · Completed: Aug 31, 2027
1 condition1 sponsor1 location
NCT04060056
Westlake Precision Birth Cohort
NAActive, not recruiting
2,001 participants
Started: Aug 30, 2019 · Completed: Aug 31, 2029
3 conditions2 sponsors1 location
NCT03995147
Pembrolizumab in Combination With Chemotherapy for Patients With Untreated B Cell Lymphoma
PHASE2Active, not recruiting
51 participants
Started: Aug 29, 2019 · Completed: Feb 20, 2027
5 conditions2 sponsors1 location
NCT03911128
A Treatment Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
N/ARecruiting
500 participants
Started: Aug 29, 2019 · Completed: Jun 30, 2033
1 condition4 sponsors53 locations
NCT03702725
Study of Ibrutinib in Combination With Revlimid/Dexamethasone in Relapsed/Refractory Multiple Myeloma
PHASE1Active, not recruiting
14 participants
Started: Aug 29, 2019 · Completed: Mar 1, 2026
3 conditions2 sponsors5 locations
NCT04801290
TIPS in Patients With Decompensated Liver Cirrhosis
N/ARecruiting
250 participants
Started: Aug 29, 2019 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT03992729
Safety Study for Prospective Assessment of Pregnancy Outcomes in Patients Treated With Tildrakizumab
N/ARecruiting
200 participants
Started: Aug 29, 2019 · Completed: Dec 1, 2025
1 condition1 sponsor1 location
NCT04100486
Non-Invasive Bioelectronic Analytics
N/AEnrolling by invitation
48 participants
Started: Aug 29, 2019 · Completed: Sep 30, 2025
4 conditions1 sponsor1 location
NCT04152512
Quality of Life, Unmet Needs and Satisfaction With Care After Vulvar Cancer
N/AActive, not recruiting
153 participants
Started: Aug 29, 2019 · Completed: Oct 31, 2027
2 conditions4 sponsors4 locations
NCT03779854
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
PHASE2Recruiting
68 participants
Started: Aug 29, 2019 · Completed: Dec 31, 2027
17 conditions2 sponsors10 locations
NCT03907488
Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma
PHASE3Active, not recruiting
994 participants
Started: Aug 29, 2019 · Completed: Mar 28, 2026
10 conditions1 sponsor731 locations
NCT04187599
Post-market Follow Up Study on Paragon CRT® 100 (Paflufocon D)
NARecruiting
250 participants
Started: Aug 29, 2019 · Completed: Dec 31, 2020
1 condition2 sponsors4 locations
NCT04065776
Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma
NARecruiting
74 participants
Started: Aug 28, 2019 · Completed: Jul 31, 2028
7 conditions1 sponsor2 locations
NCT04047849
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
PHASE4Recruiting
34 participants
Started: Aug 28, 2019 · Completed: Jul 1, 2021
6 conditions1 sponsor1 location
NCT03477435
Comparing an Opt-out to an opt-in Approach for Smoking Cessation in VA Primary Care Clinics
NAActive, not recruiting
1,365 participants
Started: Aug 28, 2019 · Completed: Apr 1, 2026
1 condition1 sponsor1 location
NCT03981146
A Phase II Trial Assessing Nivolumab in Class II Expressing Microsatellite Stable Colorectal Cancer
PHASE2Active, not recruiting
35 participants
Started: Aug 28, 2019 · Completed: Oct 1, 2024
1 condition2 sponsors14 locations
NCT03831178
Docosahexaenoic Acid (DHA) for Women With Breast Cancer in the Neoadjuvant Setting
PHASE2Active, not recruiting
76 participants
Started: Aug 28, 2019 · Completed: Sep 30, 2030
1 condition3 sponsors1 location
NCT04965961
The Effect of Micro-doses Erytropoietin on Exercise Capacity in Male and Females
NAActive, not recruiting
48 participants
Started: Aug 28, 2019 · Completed: Jan 31, 2024
1 condition1 sponsor1 location
NCT03852082
Predictors and Clinical Outcomes of Patients With Coronary Heart Disease Co-morbid Depression Post Percutaneous Coronary Intervention
N/AActive, not recruiting
2,600 participants
Started: Aug 28, 2019 · Completed: Dec 30, 2025
3 conditions1 sponsor1 location
NCT03969927
User-friendliness of a Portable Driving Simulator
NARecruiting
30 participants
Started: Aug 28, 2019 · Completed: Jun 30, 2025
3 conditions1 sponsor1 location
NCT03941730
Estradiol in Treating Patients With ER Beta Positive, Triple Negative Locally Advanced or Metastatic Breast Cancer
PHASE2Active, not recruiting
5 participants
Started: Aug 28, 2019 · Completed: Jul 31, 2026
5 conditions2 sponsors9 locations
NCT03754114
Brain Oxygen Optimization in Severe TBI, Phase 3
NARecruiting
1,094 participants
Started: Aug 28, 2019 · Completed: Nov 1, 2027
1 condition6 sponsors48 locations
NCT04013568
Exercise Post-Diagnosis of Breast Cancer
NAActive, not recruiting
165 participants
Started: Aug 28, 2019 · Completed: Sep 1, 2026
1 condition2 sponsors1 location
NCT03722407
Ruxolitinib for the Treatment of Chronic Myelomonocytic Leukemia (CMML): A Phase 2 Expansion
PHASE2Active, not recruiting
29 participants
Started: Aug 28, 2019 · Completed: Jun 1, 2026
2 conditions2 sponsors5 locations
NCT03820830
Palbociclib for HR Positive / HER2-negative Isolated Locoregional Recurrence of Breast Cancer
PHASE3Active, not recruiting
405 participants
Started: Aug 27, 2019 · Completed: Jan 1, 2029
1 condition2 sponsors53 locations
NCT05835739
InheriteD brEast caNcer iTalian regIsTrY A Retrospective-prospective Observational Cohort Study to Evaluate Cancer Prevention Strategies in Women With a Deleterious Mutation in BRCA1-2
N/ARecruiting
78 participants
Started: Aug 27, 2019 · Completed: Sep 30, 2035
1 condition1 sponsor12 locations
NCT04044963
The Effect of a Prehabilitation Exercise Program on Physical Functioning for Patients Undergoing Kidney Transplantation
NARecruiting
150 participants
Started: Aug 27, 2019 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT04067726
RANKL Inhibition and Mammographic Breast Density
PHASE2Active, not recruiting
210 participants
Started: Aug 27, 2019 · Completed: Aug 31, 2026
1 condition2 sponsors1 location
NCT04050410
Autonomic Determinants of POTS - Pilot1
EARLY_PHASE1Active, not recruiting
48 participants
Started: Aug 27, 2019 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT03957551
Cabozantinib and Pembrolizumab for Advanced Metastatic Melanoma
PHASE1/PHASE2Active, not recruiting
28 participants
Started: Aug 27, 2019 · Completed: Dec 31, 2026
1 condition3 sponsors1 location
NCT04832607
Multivirus-specific T-cell Transfer Post SCT vs AdV, CMV and EBV Infections
PHASE3Recruiting
149 participants
Started: Aug 27, 2019 · Completed: Sep 30, 2028
4 conditions10 sponsors33 locations